Potency assays. It's not about potency per se. The FDA is recently obsessed with tracking and evaluating the precise operation of the therapy.
It's odd that they are doing this, since they normally don't bother.
Indeed, many drugs and therapies get approved on the basis of correlation, the precise operation of them is not understood and nobody worries.
Cell Therapy News/Articles, page-17034
-
- There are more pages in this discussion • 787 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.013(1.07%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $1.339M | 1.144M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 2121 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 62054 | 9 |
View Market Depth
| Last trade - 11.08am 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |